Nifedipine (Adalat, BAYA1040)

DRUG6 trials

Sponsors

Bayer

Conditions

Hypertension

Phase 3

High Dose BAYA1040_Nifedipine: a Dose-comparative Study

CompletedNCT01287260

BayerHypertension

Start: 2011-01-31End: 2011-08-31Updated: 2014-01-29

High Dose BAYA1040_Nifedipine: a Long Term Combination Study

CompletedNCT01294215

BayerHypertension

Start: 2011-02-28End: 2012-06-30Updated: 2014-06-23

High Dose BAYA1040 CR: a Long Term Extension Study

CompletedNCT01355367

BayerHypertension

Start: 2011-01-31End: 2012-04-30Updated: 2014-01-29

Phase 4

FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

CompletedNCT01071122

BayerHypertension

Start: 2010-01-31End: 2012-02-29Updated: 2014-01-27

Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension

CompletedNCT01518855

BayerHypertension

Start: 2004-03-31End: 2005-04-30Updated: 2012-01-26

Unknown Phase

Treatment of Hypertension With Adalat® in Combination With Other Drugs

CompletedNCT01118286

BayerHypertension

Start: 2010-01-31End: 2011-09-30Updated: 2012-06-27

Related Papers

Safety of the Up-titration of Nifedipine GITS and Valsartan or Low-dose Combination in Uncontrolled Hypertension: the FOCUS Study.

2016-03-173 citations

Effectiveness of combination therapy with nifedipine GITS: a prospective, 12-week observational study (AdADOSE)

BMC Cardiovascular Disorders2015-05-086 citations

Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study.

2013-08-1583 citations